{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:36:19Z","timestamp":1791336979017,"version":"4.3.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Axelera"},{"DOI":"10.13039\/100009863","name":"Neuroendocrine Tumor Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009863","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Neuroendocrine Tumor Society"},{"name":"France-Stanford Centre for Interdisciplinary Studies"},{"DOI":"10.13039\/501100007287","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02721-7","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:20:23Z","timestamp":1787797223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids"],"prefix":"10.1186","volume":"25","author":[{"given":"Alexandra","family":"Sexton-Oates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Mathian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Candeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Voegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Di Genova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurane","family":"Mang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijmen","family":"van Weert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Kalson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany M.","family":"Delhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Bl\u00e1zquez-Encinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Gonzalez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Lauricella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Mangiante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bonheme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Moonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Absenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Altmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Degletagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd Terje","family":"Brustugun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cahais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Chabrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Cuenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Damiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Thomas","family":"de Montpr\u00e9ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Deleuze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9lie","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Gadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Ghantous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Graziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Ib\u00e1\u00f1ez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lacomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Lopez-Bigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Lund-Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Milione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Anna","family":"Muscarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pedraza-Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetane","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Popper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Roz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Sparaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieneke","family":"Buikhuisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Tesselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst Jan M.","family":"Speel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Tabone-Eglinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Chalabreysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vignaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mansuet-Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Brcic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Giulio","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lantuejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talya","family":"Dayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette","family":"Fernandez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2721_CR1","volume-title":"Thoracic tumours 5th edn","author":"WHO Classification of Tumours Editorial Board","year":"2021","unstructured":"WHO Classification of Tumours Editorial Board. Thoracic tumours 5th edn, vol. vol. 5. Lyon: International Agency for Research on Cancer; 2021."},{"key":"2721_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022;17:362\u201387.","journal-title":"J Thorac Oncol"},{"key":"2721_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jtho.2021.09.017","volume":"17","author":"MS Tsao","year":"2022","unstructured":"Tsao MS, Nicholson AG, Maleszewski JJ, Marx A, Travis WD. Introduction to 2021 WHO Classification of Thoracic Tumors. J Thorac Oncol. 2022;17:e1\u20134.","journal-title":"J Thorac Oncol"},{"key":"2721_CR4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/PAS.0000000000000300","volume":"38","author":"DRA Swarts","year":"2014","unstructured":"Swarts DRA, et al. Interobserver variability for the WHO classification of pulmonary carcinoids. Am J Surg Pathol. 2014;38:1429\u201336.","journal-title":"Am J Surg Pathol"},{"key":"2721_CR5","doi-asserted-by":"publisher","first-page":"103591","DOI":"10.1016\/j.esmoop.2024.103591","volume":"9","author":"\u00c9 Mathian","year":"2024","unstructured":"Mathian \u00c9, et al. Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project. ESMO Open. 2024;9:103591.","journal-title":"ESMO Open"},{"key":"2721_CR6","doi-asserted-by":"crossref","unstructured":"Alcala N, et al. Integrative and comparative genomic analyses identify clinically\u00a0relevant pulmonary carcinoid\u00a0groups and unveil the supra-carcinoids. Nat Commun. 2019;10:3407.","DOI":"10.1038\/s41467-019-11276-9"},{"key":"2721_CR7","doi-asserted-by":"crossref","unstructured":"Gabriel AAG, et al. A molecular map of lung neuroendocrine neoplasms. Gigascience. 2020;9:giaa112.","DOI":"10.1093\/gigascience\/giaa112"},{"key":"2721_CR8","doi-asserted-by":"crossref","unstructured":"Laddha SV, et al. Integrative genomic characterization identifies molecular subtypes of lung carcinoids. Cancer Res. 2019;79:4339\u201347.","DOI":"10.1158\/0008-5472.CAN-19-0214"},{"key":"2721_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jtho.2024.11.018","volume":"20","author":"DJG Leunissen","year":"2025","unstructured":"Leunissen DJG, et al. Identification of defined molecular subgroups on the basis of immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids. J Thorac Oncol. 2025;20:451\u201364.","journal-title":"J Thorac Oncol"},{"key":"2721_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11912-022-01253-9","volume":"24","author":"TY Sun","year":"2022","unstructured":"Sun TY, Hendifar A, Padda SK. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help? Curr Oncol Rep. 2022;24:819\u201324.","journal-title":"Curr Oncol Rep"},{"key":"2721_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejca.2023.03.024","volume":"186","author":"A Boil\u00e8ve","year":"2023","unstructured":"Boil\u00e8ve A, et al. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. Eur J Cancer. 2023;186:122\u201332.","journal-title":"Eur J Cancer"},{"key":"2721_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.lungcan.2020.03.027","volume":"145","author":"A Miyanaga","year":"2020","unstructured":"Miyanaga A, et al. Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence. Lung Cancer. 2020;145:85\u201394.","journal-title":"Lung Cancer"},{"key":"2721_CR13","doi-asserted-by":"crossref","unstructured":"Fernandez-Cuesta L, et al. Basic science and translational implications of current knowledge on neuroendocrine tumors. J Clin Invest. 2025;135:e186702.","DOI":"10.1172\/JCI186702"},{"key":"2721_CR14","doi-asserted-by":"publisher","first-page":"e390794","DOI":"10.1200\/EDBK_390794","volume":"43","author":"L Fernandez-Cuesta","year":"2023","unstructured":"Fernandez-Cuesta L, et al. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 2023;43:e390794.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2721_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1159\/000513249","volume":"111","author":"BCM Hermans","year":"2021","unstructured":"Hermans BCM, et al. Unique Metastatic Patterns in Neuroendocrine Neoplasms of Different Primary Origin. Neuroendocrinology. 2021;111:1111\u201320.","journal-title":"Neuroendocrinology"},{"key":"2721_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41379-019-0248-2","volume":"32","author":"N Rekhtman","year":"2019","unstructured":"Rekhtman N, et al. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices. Mod Pathol. 2019;32:1106\u201322.","journal-title":"Mod Pathol"},{"key":"2721_CR17","doi-asserted-by":"crossref","unstructured":"Argelaguet R, et al. MOFA+: A statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 2020;21:111.","DOI":"10.1186\/s13059-020-02015-1"},{"key":"2721_CR18","doi-asserted-by":"publisher","unstructured":"Kalson L, et al. A multi-omic, spatial, and whole-slide image dataset of lung neuroendocrine tumours from the lungNENomics cohort. bioRxiv 2026.05.12.724489. 2026. https:\/\/doi.org\/10.64898\/2026.05.12.724489.","DOI":"10.64898\/2026.05.12.724489"},{"key":"2721_CR19","doi-asserted-by":"crossref","unstructured":"Hausser J, Alon U. Tumour heterogeneity and the evolutionary trade-offs of cancer. Nat Rev Cancer. 2020;20:247\u201357.","DOI":"10.1038\/s41568-020-0241-6"},{"key":"2721_CR20","doi-asserted-by":"crossref","unstructured":"Hausser J, et al. Tumor diversity and the trade-off between universal cancer tasks. Nat Commun. 2019;10:5423.","DOI":"10.1038\/s41467-019-13195-1"},{"key":"2721_CR21","doi-asserted-by":"publisher","unstructured":"Morrison ML, et al. Variability of mutational signatures is a footprint of carcinogens. medRxiv 2023.11.23.23298821. 2023. https:\/\/doi.org\/10.1101\/2023.11.23.23298821.","DOI":"10.1101\/2023.11.23.23298821"},{"key":"2721_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2721_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2721_CR24","doi-asserted-by":"crossref","unstructured":"Bielski CM, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50:1189\u201395.","DOI":"10.1038\/s41588-018-0165-1"},{"key":"2721_CR25","doi-asserted-by":"crossref","unstructured":"Venet D, Dumont JE, Detours V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol. 2011;7:e10002240 .","DOI":"10.1371\/journal.pcbi.1002240"},{"key":"2721_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11:34.","journal-title":"Genome Med"},{"key":"2721_CR27","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","volume":"35","author":"G Sturm","year":"2019","unstructured":"Sturm G, et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436\u201345.","journal-title":"Bioinformatics"},{"key":"2721_CR28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"L Cassetta","year":"2023","unstructured":"Cassetta L, Pollard JW. A timeline of tumour-associated macrophage biology. Nat Rev Cancer. 2023;23:238\u201357.","journal-title":"Nat Rev Cancer"},{"key":"2721_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2021.12.004","volume":"185","author":"AJ Combes","year":"2022","unstructured":"Combes AJ, et al. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022;185:184-203.e19.","journal-title":"Cell"},{"key":"2721_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41568-023-00578-2","volume":"23","author":"AJ Combes","year":"2023","unstructured":"Combes AJ, Samad B, Krummel MF. Defining and using immune archetypes to classify and treat cancer. Nat Rev Cancer. 2023;23:491\u2013505.","journal-title":"Nat Rev Cancer"},{"key":"2721_CR31","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41588-018-0138-4","volume":"50","author":"MJ Alvarez","year":"2018","unstructured":"Alvarez MJ, et al. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat Genet. 2018;50:979\u201389.","journal-title":"Nat Genet"},{"key":"2721_CR32","doi-asserted-by":"crossref","unstructured":"Hofving T, et al. The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after Expansion. Cancers (Basel). 2021;13:4305.","DOI":"10.3390\/cancers13174305"},{"key":"2721_CR33","doi-asserted-by":"crossref","unstructured":"Greenberg J, et al. Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration. JCI Insight. 2022;7:e160130.","DOI":"10.1172\/jci.insight.160130"},{"key":"2721_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12022-024-09807-2","volume":"35","author":"S Uccella","year":"2024","unstructured":"Uccella S. Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That? Endocr Pathol. 2024;35:91\u2013106.","journal-title":"Endocr Pathol"},{"key":"2721_CR35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley D, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet. 2022;54:1192\u2013201.","journal-title":"Nat Genet"},{"key":"2721_CR36","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/ijc.33995","volume":"150","author":"P Bischoff","year":"2022","unstructured":"Bischoff P, et al. The single-cell transcriptional landscape of lung carcinoid tumors. Int J Cancer. 2022;150:2058\u201371.","journal-title":"Int J Cancer"},{"key":"2721_CR37","doi-asserted-by":"publisher","first-page":"A126","DOI":"10.1136\/esmoopen-2018-EACR25.302","volume":"3","author":"T Dayton","year":"2018","unstructured":"Dayton T, Hartigh LD, B\u00f6ttinger L, Chuva de Sousa Lopes SM, Clevers H. PO-271 Using human lung organoids to study pulmonary neuroendocrine cells. ESMO Open. 2018;3:A126.","journal-title":"ESMO Open"},{"key":"2721_CR38","doi-asserted-by":"publisher","first-page":"e2210113120","DOI":"10.1073\/pnas.2210113120","volume":"120","author":"AS Conchola","year":"2023","unstructured":"Conchola AS, et al. Regionally distinct progenitor cells in the lower airway give rise to neuroendocrine and multiciliated cells in the developing human lung. Proc Natl Acad Sci U S A. 2023;120:e2210113120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2721_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"2721_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R. ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol. 2020;108:787\u201399.","journal-title":"J Leukoc Biol"},{"key":"2721_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez F, et al. A compendium of mutational cancer driver genes. Nat Rev Cancer. 2020;20:555\u201372.","journal-title":"Nat Rev Cancer"},{"key":"2721_CR42","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:R41.","journal-title":"Genome Biol."},{"key":"2721_CR43","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41592-018-0108-x","volume":"15","author":"G Caravagna","year":"2018","unstructured":"Caravagna G, et al. Detecting repeated cancer evolution from multi-region tumor sequencing data. Nat Methods. 2018;15:707\u201314.","journal-title":"Nat Methods"},{"key":"2721_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00428-018-2307-3","volume":"472","author":"G Pelosi","year":"2018","unstructured":"Pelosi G, et al. Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm. Virchows Arch. 2018;472:567\u201377.","journal-title":"Virchows Arch"},{"key":"2721_CR45","doi-asserted-by":"publisher","first-page":"104882","DOI":"10.1016\/j.yexmp.2024.104882","volume":"135","author":"G Pelosi","year":"2024","unstructured":"Pelosi G, et al. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms. Exp Mol Pathol. 2024;135:104882.","journal-title":"Exp Mol Pathol"},{"key":"2721_CR46","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.ccell.2023.11.007","volume":"41","author":"TL Dayton","year":"2023","unstructured":"Dayton TL, et al. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 2023;41:2083-2099.e9.","journal-title":"Cancer Cell"},{"key":"2721_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature10662","volume":"480","author":"PI Poulikakos","year":"2011","unstructured":"Poulikakos PI, et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature. 2011;480:387\u201390.","journal-title":"Nature"},{"key":"2721_CR48","doi-asserted-by":"crossref","unstructured":"Fernandez-Cuesta L, et al. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun. 2014;5:3518.","DOI":"10.1038\/ncomms4518"},{"key":"2721_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2159-8290.CD-24-0286","volume":"15","author":"N Rekhtman","year":"2025","unstructured":"Rekhtman N, et al. Chromothripsis-Mediated Small Cell Lung Carcinoma. Cancer Discov. 2025;15:83\u2013104.","journal-title":"Cancer Discov"},{"key":"2721_CR50","doi-asserted-by":"crossref","unstructured":"George J, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47\u201353.","DOI":"10.1038\/nature14664"},{"key":"2721_CR51","doi-asserted-by":"crossref","unstructured":"Beasley MB, et al. IASLC Update on Classification of Pulmonary Neuroendocrine Neoplasms. J Thoracic Oncol. 2026; Jun 6:103977.","DOI":"10.1016\/j.jtho.2026.103977"},{"key":"2721_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12885-022-09391-w","volume":"22","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma. BMC Cancer. 2022;22:321.","journal-title":"BMC Cancer"},{"key":"2721_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.lungcan.2020.10.015","volume":"150","author":"BCM Hermans","year":"2020","unstructured":"Hermans BCM, et al. Pulmonary neuroendocrine neoplasms with well differentiated morphology and high proliferative activity: illustrated by a case series and review of the literature. Lung Cancer. 2020;150:152\u20138.","journal-title":"Lung Cancer"},{"key":"2721_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/PAS.0000000000000767","volume":"41","author":"AM Quinn","year":"2017","unstructured":"Quinn AM, Chaturvedi A, Nonaka D. High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 Cases. Am J Surg Pathol. 2017;41:263\u201370.","journal-title":"Am J Surg Pathol"},{"key":"2721_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000506292","volume":"111","author":"J Cros","year":"2021","unstructured":"Cros J, et al. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology. Neuroendocrinology. 2021;111:158\u201369.","journal-title":"Neuroendocrinology"},{"key":"2721_CR56","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab JE, et al. A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019;177:821-836.e16.","journal-title":"Cell"},{"key":"2721_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41588-023-01313-1","volume":"55","author":"L Zapata","year":"2023","unstructured":"Zapata L, et al. Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. Nat Genet. 2023;55:451\u201360.","journal-title":"Nat Genet"},{"key":"2721_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am J Hum Genet. 2017;100:267\u201380.","journal-title":"Am J Hum Genet"},{"key":"2721_CR59","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini KJ, et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature. 2020;587:619\u201325.","journal-title":"Nature"},{"key":"2721_CR60","doi-asserted-by":"publisher","first-page":"eabf6123","DOI":"10.1126\/sciadv.abf6123","volume":"7","author":"J Reddy","year":"2021","unstructured":"Reddy J, et al. Predicting master transcription factors from pan-cancer expression data. Sci Adv. 2021;7:eabf6123.","journal-title":"Sci Adv."},{"key":"2721_CR61","doi-asserted-by":"crossref","unstructured":"Kuo CS, et al. Neuroendocrinology of the lung revealed by single-cell RNA sequencing. Elife. 2022;11:e78216.","DOI":"10.7554\/eLife.78216"},{"key":"2721_CR62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature21722","volume":"544","author":"M Mall","year":"2017","unstructured":"Mall M, et al. Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates. Nature. 2017;544:245\u20139.","journal-title":"Nature"},{"key":"2721_CR63","unstructured":"Zbontar J, Jing L, Misra I, LeCun Y, Deny S. Barlow Twins: Self-Supervised Learning via Redundancy Reduction. Proceedings of the 38th International Conference on Machine Learning. 2021;139:12310-12320."},{"key":"2721_CR64","doi-asserted-by":"crossref","unstructured":"Pochet E, Maroun R, Trullo R. RoFormer for Position Aware Multiple Instance Learning in Whole Slide Image Classification. Int Workshop Mach Learn Med Imaging. 2023:437-446.","DOI":"10.1007\/978-3-031-45676-3_44"},{"key":"2721_CR65","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41591-024-02856-4","volume":"30","author":"MY Lu","year":"2024","unstructured":"Lu MY, et al. A visual-language foundation model for computational pathology. Nat Med. 2024;30:863\u201374.","journal-title":"Nat Med"},{"key":"2721_CR66","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1200\/JCO.23.02708","volume":"43","author":"L Werr","year":"2025","unstructured":"Werr L, et al. TERT Expression and Clinical Outcome in Pulmonary Carcinoids. J Clin Oncol. 2025;43:214\u201325.","journal-title":"J Clin Oncol"},{"key":"2721_CR67","doi-asserted-by":"publisher","first-page":"e2405001121","DOI":"10.1073\/pnas.2405001121","volume":"121","author":"E Davis","year":"2024","unstructured":"Davis E, et al. Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications. Proc Natl Acad Sci U S A. 2024;121:e2405001121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2721_CR68","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41571-024-00914-x","volume":"21","author":"T Sen","year":"2024","unstructured":"Sen T, et al. Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer. Nat Rev Clin Oncol. 2024;21:610\u201327.","journal-title":"Nat Rev Clin Oncol"},{"key":"2721_CR69","first-page":"100750","volume":"5","author":"AJ Cooper","year":"2024","unstructured":"Cooper AJ, et al. First Report of Response to Tarlatamab in a Patient With DLL3-Positive Pulmonary Carcinoid: Case Report. JTO Clin Res Rep. 2024;5:100750.","journal-title":"JTO Clin Res Rep"},{"key":"2721_CR70","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224\u201333.","journal-title":"N Engl J Med"},{"key":"2721_CR71","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009;27:4656\u201363.","journal-title":"J Clin Oncol"},{"key":"2721_CR72","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1200\/JCO.22.01013","volume":"41","author":"PL Kunz","year":"2023","unstructured":"Kunz PL, et al. Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). J Clin Oncol. 2023;41:1359\u201369.","journal-title":"J Clin Oncol"},{"key":"2721_CR73","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1200\/JCO.23.02724","volume":"43","author":"T Walter","year":"2025","unstructured":"Walter T, et al. Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET). J Clin Oncol. 2025;43:960\u201371.","journal-title":"J Clin Oncol"},{"key":"2721_CR74","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127:2930\u201340.","journal-title":"J Clin Invest"},{"key":"2721_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12022-018-9530-y","volume":"29","author":"G Papaxoinis","year":"2018","unstructured":"Papaxoinis G, Lamarca A, Quinn AM, Mansoor W, Nonaka D. Clinical and pathologic characteristics of pulmonary carcinoid tumors in central and peripheral locations. Endocr Pathol. 2018;29:259\u201368.","journal-title":"Endocr Pathol"},{"key":"2721_CR76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12022-025-09882-z","volume":"36","author":"A Ura","year":"2025","unstructured":"Ura A, et al. Phenotypic Landscape of Pulmonary Neuroendocrine Tumors: Subtyped by OTP\/ASCL1 Expression Correlated with Histology, Hormones and Outcome. Endocr Pathol. 2025;36:43.","journal-title":"Endocr Pathol"},{"key":"2721_CR77","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1164\/rccm.201710-2107OC","volume":"198","author":"W-L Zuo","year":"2018","unstructured":"Zuo W-L, et al. Ontogeny and biology of human small airway epithelial club cells. Am J Respir Crit Care Med. 2018;198:1375\u201388.","journal-title":"Am J Respir Crit Care Med"},{"key":"2721_CR78","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41416-019-0722-0","volume":"122","author":"EP Allain","year":"2020","unstructured":"Allain EP, Rouleau M, L\u00e9vesque E, Guillemette C. Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression. Br J Cancer. 2020;122:1277\u201387.","journal-title":"Br J Cancer"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02721-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:20:29Z","timestamp":1787797229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02721-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2721"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02721-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the International Agency for Research on Cancer Ethics Committee (project number 19\u201307).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Where authors are identified as personnel of the International Agency for Research on Cancer\/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer\/World Health Organization. Nicolas Girard has research support from Abbvie, Amgen, AstraZeneca, Beigene, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi-Sankyo, Gilead, Hoffmann-La Roche, Janssen, LeoPharma, Lilly, Merk Serono, Merck Sharp & Dohme, Novartis, Sanofi, Sivan; he also has consultative services for Abbvie, Amgen, AstraZeneca, Beigene, Bristol Myers Squibb, Daiichi-Sankyo, Gilead, Ipsen Hoffmann-La Roche, Janssen, LeoPharma, Lilly, Merck Sharp & Dohme, Mirati, Novartis, Pfizer, Pierre Fabre, Sanofi, Sivan Takeda; and he participates on a data safety monitoring board for Hoffmann-La Roche. Ernst-Jan M Speel has grant support from Pfizer, and participates on advisory boards for AstraZeneca, GSK, Johnson & Johnson, and Illumina.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"204"}}